{"filing":{"accession_number":"0000049071-26-000027","cik":"0000049071","ticker":"HUM","company_name":"HUMANA INC","form":"8-K","filing_date":"2026-06-01","report_date":null,"primary_document":"hum-20260601.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/49071/000004907126000027/hum-20260601.htm"},"events":[{"id":7651,"run_id":6726,"accession_number":"0000049071-26-000027","anchor_item_number":"7.01","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.75,"summary":"Humana is reaffirming its FY 2026 earnings guidance (at least $8.36 diluted EPS and at least $9.00 adjusted EPS) in advance of investor meetings scheduled through June 30, 2026. While technically a Regulation FD disclosure rather than a formal earnings release, the disclosure centers on quantified earnings guidance and includes a reconciliation of GAAP to non-GAAP metrics, which is characteristic of earnings-related guidance updates. The materiality and forward-looking nature of specific EPS targets make this a significant disclosure to investors.","company_name":"HUMANA INC","ticker":"HUM","filing_date":"2026-06-01","form":"8-K","submitted_at":null,"items":[{"id":2929,"accession_number":"0000049071-26-000027","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"Humana is reaffirming its FY 2026 earnings guidance (at least $8.36 diluted EPS and at least $9.00 adjusted EPS) in advance of investor meetings scheduled through June 30, 2026. While technically a Regulation FD disclosure rather than a formal earnings release, the disclosure centers on quantified earnings guidance and includes a reconciliation of GAAP to non-GAAP metrics, which is characteristic of earnings-related guidance updates. The materiality and forward-looking nature of specific EPS targets make this a significant disclosure to investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-02T02:10:31.596156+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":2929,"accession_number":"0000049071-26-000027","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"Humana is reaffirming its FY 2026 earnings guidance (at least $8.36 diluted EPS and at least $9.00 adjusted EPS) in advance of investor meetings scheduled through June 30, 2026. While technically a Regulation FD disclosure rather than a formal earnings release, the disclosure centers on quantified earnings guidance and includes a reconciliation of GAAP to non-GAAP metrics, which is characteristic of earnings-related guidance updates. The materiality and forward-looking nature of specific EPS targets make this a significant disclosure to investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-02T02:10:31.596156+00:00","company_name":"HUMANA INC","ticker":"HUM","filing_date":"2026-06-01"}]}